Gaelle Mercenne is now head of biology for Seattle’s Talus Bioscience. The startup last month announced $11.2 million in new funding to advance its drug discovery program for hard-to-treat diseases.

A financial partner with Talus, the delayed luxury resort planned in La Quinta, filed a civil lawsuit earlier this month against the project’s lead developer and his companies, saying they ...